Entry Detail



General Information

Database ID:exR0005618
RNA Name:GDI2
RNA Type:mRNA
Chromosome:chr10
Starnd:-
Coordinate:
Start Site(bp):5765223End Site(bp):5842132
External Links:ENSG00000057608



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADH5
chr4
99070978
99088801
-
ABHD17A
chr19
1876810
1885547
-
ADIPOR2
chr12
1688574
1788674
+
ACAA2
chr18
49782164
49813953
-
AC026954.2
chr17
7312661
7319174
-
AC010422.3
chr19
12643831
12648397
-
AC245033.1
chr15
82536788
82573194
-
AC008763.2
chr19
7629796
7643048
+
ADCY6
chr12
48766194
48789037
-
ADO
chr10
62804720
62808479
+
ACTB
chr7
5527148
5563784
-
ADK
chr10
74151202
74709963
+
AC073283.3
chr2
47065941
47176511
-
ACADVL
chr17
7217125
7225266
+
ALDOA
chr16
30064164
30070457
+
AD000671.1
chr19
35745678
35754519
+
ACADM
chr1
75724347
75787575
+
ADCY2
chr5
7396138
7830081
+
ADAMTS19
chr5
129460281
129738683
+
ADAMTS13
chr9
133414358
133459402
+
ACTG1
chr17
81509971
81523847
-
ACSL3
chr2
222860942
222944639
+
AC073508.2
chr17
40627356
40665141
-
AFDN
chr6
167826922
167972023
+
AFG3L2
chr18
12328944
12377227
-
ACOT9
chrX
23701055
23766475
-
ALDH18A1
chr10
95605941
95656711
-
AC000093.1
chr22
19717220
19724772
+
ACSS2
chr20
34872146
34927962
+
ABHD17B
chr9
71862452
71910931
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC009446.1
chr8
71675300
71702786
+
AC010542.4
chr16
66549280
66551189
+
AC016876.2
chr17
7581964
7584086
-
AC124068.2
chr15
89335053
89336161
+
AC147067.1
chr4
1574062
1580253
-
AC245033.4
chr15
82533175
82540008
-
AL021707.2
chr22
38667585
38681847
-
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.